Literature DB >> 30679616

Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach.

Robert Kueffner1, Neta Zach2, Maya Bronfeld3, Raquel Norel4, Nazem Atassi5, Venkat Balagurusamy4, Barbara Di Camillo6, Adriano Chio7, Merit Cudkowicz5, Donna Dillenberger4, Javier Garcia-Garcia8, Orla Hardiman9, Bruce Hoff10, Joshua Knight4, Melanie L Leitner11, Guang Li12, Lara Mangravite10, Thea Norman10, Liuxia Wang13, Jinfeng Xiao14, Wen-Chieh Fang15, Jian Peng14, Chen Yang16, Huan-Jui Chang17, Gustavo Stolovitzky4.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease where substantial heterogeneity in clinical presentation urgently requires a better stratification of patients for the development of drug trials and clinical care. In this study we explored stratification through a crowdsourcing approach, the DREAM Prize4Life ALS Stratification Challenge. Using data from >10,000 patients from ALS clinical trials and 1479 patients from community-based patient registers, more than 30 teams developed new approaches for machine learning and clustering, outperforming the best current predictions of disease outcome. We propose a new method to integrate and analyze patient clusters across methods, showing a clear pattern of consistent and clinically relevant sub-groups of patients that also enabled the reliable classification of new patients. Our analyses reveal novel insights in ALS and describe for the first time the potential of a crowdsourcing to uncover hidden patient sub-populations, and to accelerate disease understanding and therapeutic development.

Entities:  

Year:  2019        PMID: 30679616      PMCID: PMC6345935          DOI: 10.1038/s41598-018-36873-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  57 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Functional outcome measures as clinical trial endpoints in ALS.

Authors:  B J Traynor; H Zhang; J M Shefner; D Schoenfeld; M E Cudkowicz
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

3.  Prognosis in amyotrophic lateral sclerosis: a population-based study.

Authors:  M A del Aguila; W T Longstreth; V McGuire; T D Koepsell; G van Belle
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

4.  Amyotrophic lateral sclerosis: early predictors of prolonged survival.

Authors:  Adam Czaplinski; Albert A Yen; Stanley H Appel
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

5.  Disease progression in amyotrophic lateral sclerosis: predictors of survival.

Authors:  T Magnus; M Beck; R Giess; I Puls; M Naumann; K V Toyka
Journal:  Muscle Nerve       Date:  2002-05       Impact factor: 3.217

6.  Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

Authors:  Paul H Gordon; Dan H Moore; Robert G Miller; Julaine M Florence; Joseph L Verheijde; Carolyn Doorish; Joan F Hilton; G Mark Spitalny; Robert B MacArthur; Hiroshi Mitsumoto; Hans E Neville; Kevin Boylan; Tahseen Mozaffar; Jerry M Belsh; John Ravits; Richard S Bedlack; Michael C Graves; Leo F McCluskey; Richard J Barohn; Rup Tandan
Journal:  Lancet Neurol       Date:  2007-11-05       Impact factor: 44.182

7.  Causes of death in a post-mortem series of ALS patients.

Authors:  Philippe Corcia; Pierre-François Pradat; François Salachas; Gaëlle Bruneteau; Nadine le Forestier; Danielle Seilhean; Jean-Jacques Hauw; Vincent Meininger
Journal:  Amyotroph Lateral Scler       Date:  2008

Review 8.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Authors:  R G Miller; J D Mitchell; M Lyon; D H Moore
Journal:  Cochrane Database Syst Rev       Date:  2002

9.  Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.

Authors:  Alessandra Calábria Baxmann; Marion Souza Ahmed; Natália Cristina Marques; Viviane Barcellos Menon; Aparecido Bernardo Pereira; Gianna Mastroianni Kirsztajn; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

10.  Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival.

Authors:  Robert L Vender; David Mauger; Susan Walsh; Shoaib Alam; Zachary Simmons
Journal:  Amyotroph Lateral Scler       Date:  2007-02
View more
  15 in total

1.  Prognostic models for amyotrophic lateral sclerosis: a systematic review.

Authors:  Lu Xu; Bingjie He; Yunjing Zhang; Lu Chen; Dongsheng Fan; Siyan Zhan; Shengfeng Wang
Journal:  J Neurol       Date:  2021-03-10       Impact factor: 4.849

2.  What is Evidence-Based Functional Medicine in the 21st Century?

Authors:  Jeffrey S Bland
Journal:  Integr Med (Encinitas)       Date:  2019-06

Review 3.  The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health.

Authors:  Maximillian Taro William Lee; William Mahy; Mark David Rackham
Journal:  RSC Med Chem       Date:  2021-06-04

4.  Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study.

Authors:  Faraz Faghri; Fabian Brunn; Anant Dadu; Elisabetta Zucchi; Ilaria Martinelli; Letizia Mazzini; Rosario Vasta; Antonio Canosa; Cristina Moglia; Andrea Calvo; Michael A Nalls; Roy H Campbell; Jessica Mandrioli; Bryan J Traynor; Adriano Chiò
Journal:  Lancet Digit Health       Date:  2022-03-24

5.  Machine learning can predict survival of patients with heart failure from serum creatinine and ejection fraction alone.

Authors:  Davide Chicco; Giuseppe Jurman
Journal:  BMC Med Inform Decis Mak       Date:  2020-02-03       Impact factor: 2.796

6.  Modeling and Bioinformatics Identify Responders to G-CSF in Patients With Amyotrophic Lateral Sclerosis.

Authors:  Siw Johannesen; J Russell Huie; Bettina Budeus; Sebastian Peters; Anna M Wirth; Sabine Iberl; Tina Kammermaier; Ines Kobor; Eva Wirkert; Sabrina Küspert; Marlene Tahedl; Jochen Grassinger; Tobias Pukrop; Armin Schneider; Ludwig Aigner; Wilhelm Schulte-Mattler; Gerhard Schuierer; Winfried Koch; Tim-Henrik Bruun; Adam R Ferguson; Ulrich Bogdahn
Journal:  Front Neurol       Date:  2021-03-18       Impact factor: 4.003

7.  Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes.

Authors:  Cátia Gomes; Catarina Sequeira; Shibi Likhite; Cassandra N Dennys; Stephen J Kolb; Pamela J Shaw; Ana R Vaz; Brian K Kaspar; Kathrin Meyer; Dora Brites
Journal:  Cells       Date:  2022-04-01       Impact factor: 6.600

8.  Exploiting mutual information for the imputation of static and dynamic mixed-type clinical data with an adaptive k-nearest neighbours approach.

Authors:  Erica Tavazzi; Sebastian Daberdaku; Rosario Vasta; Andrea Calvo; Adriano Chiò; Barbara Di Camillo
Journal:  BMC Med Inform Decis Mak       Date:  2020-08-20       Impact factor: 2.796

9.  Survival prediction of patients with sepsis from age, sex, and septic episode number alone.

Authors:  Davide Chicco; Giuseppe Jurman
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

10.  Characterisation, identification, clustering, and classification of disease.

Authors:  A J Webster; K Gaitskell; I Turnbull; B J Cairns; R Clarke
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.